Camlin Fine Sciences Limited
CAMLINFINE.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.28B
Close$
$-76.48
180.4% downside
Current Fair Value
180.4% downsideOvervalued by 180.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.28 Billion |
|---|---|
| Enterprise Value | $17.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.46 |
| Beta | 0.68 |
| Outstanding Shares | 192,100,000 |
Return
| Return on Equity | 0.59% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 346.08 |
|---|---|
| PEG | 158.52 |
| Price to Sales | 0.99 |
| Price to Book Ratio | 1.83 |
| Enterprise Value to Revenue | 0.93 |
| Enterprise Value to EBIT | 221.1 |
| Enterprise Value to Net Income | 293 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$0.12
Average shareholder expectationRevenue Estimate
$5.11 B
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
$5.31 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Camlin Fine Sciences Limited
624 employees
CEO: Ashish Subhash Dandekar Camlin Fine Sciences Limited, along with its subsidiaries, is actively engaged globally in the research, development, manufacturing, and distribution of specialized chemical products, functional ingredients, and additive blends. The comp...